{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:18:12Z","timestamp":1788326292106,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T00:00:00Z","timestamp":1639872000000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81871985"],"award-info":[{"award-number":["81871985"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2018A0303130098"],"award-info":[{"award-number":["2018A0303130098"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013093","name":"Science and Technology Planning Project of Shenzhen Municipality","doi-asserted-by":"publisher","award":["2017A020215112"],"award-info":[{"award-number":["2017A020215112"]}],"id":[{"id":"10.13039\/501100013093","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Planning Project of Guangzhou","award":["201903010017 and 201904010479"],"award-info":[{"award-number":["201903010017 and 201904010479"]}]},{"name":"Medical Innovation Project of the First Affiliated Hospital of Guangzhou University of Chinese Medicine","award":["2019IIT18"],"award-info":[{"award-number":["2019IIT18"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The accuracy of existing biomarkers for predicting the prognosis of hepatocellular carcinoma (HCC) is not satisfactory. It is necessary to explore biomarkers that can accurately predict the prognosis of HCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, original transcriptome data were downloaded from The Cancer Genome Atlas (TCGA) database. Immune-related long noncoding ribonucleic acids (irlncRNAs) were identified by coexpression analysis, and differentially expressed irlncRNA (DEirlncRNA) pairs were distinguished by univariate analysis. In addition, the least absolute shrinkage and selection operator (LASSO) penalized regression was modified. Next, the cutoff point was determined based on the area under the curve (AUC) and Akaike information criterion (AIC) values of the 5-year receiver operating characteristic (ROC) curve to establish an optimal model for identifying high-risk and low-risk groups of HCC patients. The model was then reassessed in terms of clinicopathological features, survival rate, tumor-infiltrating immune cells, immunosuppressive markers, and chemotherapy efficacy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 1009 pairs of DEirlncRNAs were recognized in this study, 30 of these pairs were included in the Cox regression model for subsequent analysis. After regrouping according to the cutoff point, we could more effectively identify factors such as aggressive clinicopathological features, poor survival outcomes, specific immune cell infiltration status of tumors, high expression level of immunosuppressive biomarkers, and low sensitivity to chemotherapy drugs in HCC patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The nonspecific expression level signature involved with irlncRNAs shows promising clinical value in predicting the prognosis of HCC patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-09059-x","type":"journal-article","created":{"date-parts":[[2021,12,19]],"date-time":"2021-12-19T07:02:23Z","timestamp":1639897343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Min","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Bao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Ce","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ping","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7530-8902","authenticated-orcid":false,"given":"Rong-Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,19]]},"reference":[{"issue":"15","key":"9059_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u201362.","journal-title":"N Engl J Med"},{"key":"9059_CR2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"9059_CR3","doi-asserted-by":"crossref","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u201314.","DOI":"10.1016\/S0140-6736(18)30010-2"},{"key":"9059_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","volume":"19","author":"JJ Havel","year":"2019","unstructured":"Havel JJ, Chowell D, Chan TA. The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer. 2019;19:133\u201350.","journal-title":"Nat Rev Cancer"},{"key":"9059_CR5","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, et al. Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 2017;389:2492\u2013502.","journal-title":"Lancet"},{"key":"9059_CR6","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020;382:1894\u2013905.","journal-title":"N Engl J Med"},{"key":"9059_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S1470-2045(18)30351-6","volume":"19","author":"AX Zhu","year":"2018","unstructured":"Zhu AX, Finn RS, Edeline J, Cattan S, Ogasawara S, Palmer D, et al. Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial. Lancet Oncol. 2018;19:940\u201352.","journal-title":"Lancet Oncol"},{"key":"9059_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tibs.2018.09.012","volume":"44","author":"X Qian","year":"2019","unstructured":"Qian X, Zhao J, Yeung PY, Zhang QC, Kwok CK. Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem Sci. 2019;44:33\u201352.","journal-title":"Trends Biochem Sci"},{"key":"9059_CR9","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839:1097\u2013109.","journal-title":"Biochim Biophys Acta"},{"key":"9059_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbrc.2018.07.072","volume":"503","author":"X Sun","year":"2018","unstructured":"Sun X, Zheng H, Sui N. Regulation mechanism of long non-coding RNA in plant response to stress. Biochem Biophys Res Commun. 2018;503:402\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"9059_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nrg.2015.10","volume":"17","author":"JJ Quinn","year":"2016","unstructured":"Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17:47\u201362.","journal-title":"Nat Rev Genet"},{"key":"9059_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2019.194419","volume":"1863","author":"EK Robinson","year":"2020","unstructured":"Robinson EK, Covarrubias S, Carpenter S. The how and why of lncRNA function: an innate immune perspective. Biochim Biophys Acta Gene Regul Mech. 2020;1863:194419.","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"9059_CR13","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrgastro.2013.87-c1","volume":"10","author":"J Zhao","year":"2013","unstructured":"Zhao J, Lawless MW. Long noncoding RNAs and their role in the liver cancer axis. Nat Rev Gastroenterol Hepatol. 2013;10:703.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"9059_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long noncoding RNAs in Cancer pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"9059_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-immunol-041015-055459","volume":"35","author":"MK Atianand","year":"2017","unstructured":"Atianand MK, Caffrey DR, Fitzgerald KA. Immunobiology of long noncoding RNAs. Annu Rev Immunol. 2017;35:177\u201398.","journal-title":"Annu Rev Immunol"},{"key":"9059_CR16","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/ni.3771","volume":"18","author":"YG Chen","year":"2017","unstructured":"Chen YG, Satpathy AT, Chang HY. Gene regulation in the immune system by long noncoding RNAs. Nat Immunol. 2017;18:962\u201372.","journal-title":"Nat Immunol"},{"key":"9059_CR17","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/iub.2124","volume":"71","author":"D Peng","year":"2019","unstructured":"Peng D, Wang L, Li H, Cai C, Tan Y, Xu B, et al. An immune infiltration signature to predict the overall survival of patients with colon cancer. IUBMB Life. 2019;71:1760\u201370.","journal-title":"IUBMB Life"},{"key":"9059_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102850","volume":"57","author":"ZW Wei","year":"2020","unstructured":"Wei ZW, Wu J, Huang WB, Li J, Lu XF, Yuan YJ, et al. Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour. EBioMedicine. 2020;57:102850.","journal-title":"EBioMedicine"},{"key":"9059_CR19","doi-asserted-by":"publisher","first-page":"730","DOI":"10.21037\/atm.2019.11.117","volume":"7","author":"B Zhang","year":"2019","unstructured":"Zhang B, Wang Q, Fu C, Jiang C, Ma S. Exploration of the immune-related signature and immune infiltration analysis for breast ductal and lobular carcinoma. Ann Transl Med. 2019;7:730.","journal-title":"Ann Transl Med"},{"key":"9059_CR20","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.eururo.2018.07.032","volume":"74","author":"L Qu","year":"2018","unstructured":"Qu L, Wang ZL, Chen Q, Li YM, He HW, Hsieh JJ, et al. Prognostic value of a long non-coding RNA signature in localized clear cell renal cell carcinoma. Eur Urol. 2018;74:756\u201363.","journal-title":"Eur Urol"},{"key":"9059_CR21","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1038\/s41467-018-04006-0","volume":"9","author":"Z Li","year":"2018","unstructured":"Li Z, Zhang J, Liu X, Li S, Wang Q, Chen D, et al. The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nat Commun. 2018;9:1572.","journal-title":"Nat Commun"},{"key":"9059_CR22","first-page":"8765461","volume":"2020","author":"X Zhao","year":"2020","unstructured":"Zhao X, Bai Z, Li C, Sheng C, Li H. Identification of a novel eight-lncRNA prognostic signature for HBV-HCC and analysis of their functions based on Coexpression and ceRNA networks. Biomed Res Int. 2020;2020:8765461.","journal-title":"Biomed Res Int"},{"key":"9059_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.661758","volume":"11","author":"P Zhou","year":"2021","unstructured":"Zhou P, Lu Y, Zhang Y, Wang L. Construction of an immune-related six-lncRNA signature to predict the outcomes, immune cell infiltration, and immunotherapy response in patients with hepatocellular carcinoma. Front Oncol. 2021;11:661758.","journal-title":"Front Oncol"},{"key":"9059_CR24","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1093\/carcin\/bgx078","volume":"38","author":"HC Wu","year":"2017","unstructured":"Wu HC, Yang HI, Wang Q, Chen CJ, Santella RM. Plasma DNA methylation marker and hepatocellular carcinoma risk prediction model for the general population. Carcinogenesis. 2017;38:1021\u20138.","journal-title":"Carcinogenesis."},{"key":"9059_CR25","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1093\/bib\/bbz131","volume":"21","author":"Y Lv","year":"2020","unstructured":"Lv Y, Lin SY, Hu FF, Ye Z, Zhang Q, Wang Y, et al. Landscape of cancer diagnostic biomarkers from specifically expressed genes. Brief Bioinformatics. 2020;21:2175\u201384.","journal-title":"Brief Bioinformatics"},{"key":"9059_CR26","doi-asserted-by":"publisher","first-page":"9304","DOI":"10.1002\/jcp.29730","volume":"235","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang L, Xu Y, Wu X, Zhou Y, Mo J. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. J Cell Physiol. 2020;235:9304\u201316.","journal-title":"J Cell Physiol"},{"key":"9059_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12935-021-02170-w","volume":"21","author":"Y Wu","year":"2021","unstructured":"Wu Y, Wang L, Wang X, Zhao Y, Mao A, Zhang N, et al. RNA sequencing analysis reveals the competing endogenous RNAs interplay in resected hepatocellular carcinoma patients who received interferon-alpha therapy. Cancer Cell Int. 2021;21:464.","journal-title":"Cancer Cell Int"},{"key":"9059_CR28","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.omtn.2020.10.002","volume":"22","author":"W Hong","year":"2020","unstructured":"Hong W, Liang L, Gu Y, Qi Z, Qiu H, Yang X, et al. Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma. Mol Ther Nucleic Acids. 2020;22:937\u201347.","journal-title":"Mol Ther Nucleic Acids"},{"key":"9059_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.689224","volume":"8","author":"J Yin","year":"2021","unstructured":"Yin J, Li X, Lv C, He X, Luo X, Li S, et al. Immune-related lncRNA signature for predicting the immune landscape of head and neck squamous cell carcinoma. Front Mol Biosci. 2021;8:689224.","journal-title":"Front Mol Biosci"},{"key":"9059_CR30","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11427-013-4553-6","volume":"56","author":"J Zhu","year":"2013","unstructured":"Zhu J, Fu H, Wu Y, Zheng X. Function of lncRNAs and approaches to lncRNA-protein interactions. Sci China Life Sci. 2013;56:876\u201385.","journal-title":"Sci China Life Sci"},{"key":"9059_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3727\/096504016X14549667334007","volume":"23","author":"J Li","year":"2016","unstructured":"Li J, Meng H, Bai Y, Wang K. Regulation of lncRNA and its role in Cancer metastasis. Oncol Res. 2016;23:205\u201317.","journal-title":"Oncol Res"},{"key":"9059_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12943-020-01188-4","volume":"19","author":"Z Huang","year":"2020","unstructured":"Huang Z, Zhou JK, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19:77.","journal-title":"Mol Cancer"},{"key":"9059_CR33","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1111\/cas.13642","volume":"109","author":"A Sanchez Calle","year":"2018","unstructured":"Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109:2093\u2013100.","journal-title":"Cancer Sci"},{"key":"9059_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-016-0544-0","volume":"15","author":"X Zhu","year":"2016","unstructured":"Zhu X, Tian X, Yu C, Shen C, Yan T, Hong J, et al. A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Mol Cancer. 2016;15:60.","journal-title":"Mol Cancer"},{"key":"9059_CR35","doi-asserted-by":"crossref","unstructured":"Alessio E, Bonadio RS, Buson L, Chemello F, Cagnin S. A single cell but many different transcripts: a journey into the world of long non-coding RNAs. Int J Mol Sci.\u00a02020;21(1):302.","DOI":"10.3390\/ijms21010302"},{"key":"9059_CR36","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.molcel.2011.08.018","volume":"43","author":"KC Wang","year":"2011","unstructured":"Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43:904\u201314.","journal-title":"Mol Cell"},{"key":"9059_CR37","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and Cancer: a new paradigm. Cancer Res. 2017;77:3965\u201381.","journal-title":"Cancer Res"},{"key":"9059_CR38","doi-asserted-by":"crossref","unstructured":"Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in Cancer. Int J Mol Sci.\u00a02018;19(5):1310.","DOI":"10.3390\/ijms19051310"},{"key":"9059_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-981-10-5203-3_7","volume":"1008","author":"A Renganathan","year":"2017","unstructured":"Renganathan A, Felley-Bosco E. Long noncoding RNAs in Cancer and therapeutic potential. Adv Exp Med Biol. 2017;1008:199\u2013222.","journal-title":"Adv Exp Med Biol"},{"key":"9059_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020422","volume":"99","author":"B Deng","year":"2020","unstructured":"Deng B, Yang M, Wang M, Liu Z. Development and validation of 9-long non-coding RNA signature to predicting survival in hepatocellular carcinoma. Medicine (Baltimore). 2020;99:e20422.","journal-title":"Medicine (Baltimore)"},{"key":"9059_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-019-1063-6","volume":"18","author":"M Xu","year":"2019","unstructured":"Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18:135.","journal-title":"Mol Cancer"},{"key":"9059_CR42","doi-asserted-by":"publisher","first-page":"15129","DOI":"10.1038\/ncomms15129","volume":"8","author":"R Jiang","year":"2017","unstructured":"Jiang R, Tang J, Chen Y, Deng L, Ji J, Xie Y, et al. The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion. Nat Commun. 2017;8:15129.","journal-title":"Nat Commun"},{"key":"9059_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110339","volume":"129","author":"Q You","year":"2020","unstructured":"You Q, Yao Y, Wu J, Cheng C, Li Y, Yuan H. YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p\/YY1 axis. Biomed Pharmacother. 2020;129:110339.","journal-title":"Biomed Pharmacother"},{"key":"9059_CR44","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-018-0937-7","volume":"9","author":"Y Wang","year":"2018","unstructured":"Wang Y, Sun L, Wang L, Liu Z, Li Q, Yao B, et al. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt\/\u03b2-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis. 2018;9:851.","journal-title":"Cell Death Dis"},{"key":"9059_CR45","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1158\/1078-0432.CCR-11-3302","volume":"18","author":"A Sveen","year":"2012","unstructured":"Sveen A, \u00c5gesen TH, Nesbakken A, Meling GI, Rognum TO, Liest\u00f8l K, et al. ColoGuidePro: a prognostic 7-gene expression signature for stage III colorectal cancer patients. Clin Cancer Res. 2012;18:6001\u201310.","journal-title":"Clin Cancer Res"},{"key":"9059_CR46","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","volume":"153","author":"G Zhou","year":"2017","unstructured":"Zhou G, Sprengers D, Boor P, Doukas M, Schutz H, Mancham S, et al. Antibodies against immune checkpoint molecules restore functions of tumor-infiltrating T cells in hepatocellular carcinomas. Gastroenterology. 2017;153:1107\u20131119.e10.","journal-title":"Gastroenterology"},{"key":"9059_CR47","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-1-0716-0327-7_19","volume":"2120","author":"D Aran","year":"2020","unstructured":"Aran D. Cell-type enrichment analysis of bulk Transcriptomes using xCell. Methods Mol Biol. 2020;2120:263\u201376.","journal-title":"Methods Mol Biol"},{"key":"9059_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220.","journal-title":"Genome Biol"},{"key":"9059_CR49","first-page":"e108-108e110","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77:e108-108e110.","journal-title":"Cancer Res"},{"key":"9059_CR50","first-page":"W509-509W514","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509-509W514.","journal-title":"Nucleic Acids Res"},{"key":"9059_CR51","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13073-019-0638-6","volume":"11","author":"F Finotello","year":"2019","unstructured":"Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, et al. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. 2019;11:34.","journal-title":"Genome Med"},{"key":"9059_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/bs.mie.2019.05.056","volume":"636","author":"C Plattner","year":"2020","unstructured":"Plattner C, Finotello F, Rieder D. Deconvoluting tumor-infiltrating immune cells from RNA-seq data using quanTIseq. Meth Enzymol. 2020;636:261\u201385.","journal-title":"Meth Enzymol"},{"key":"9059_CR53","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/annonc\/mdz287","volume":"30","author":"R Dienstmann","year":"2019","unstructured":"Dienstmann R, Villacampa G, Sveen A, Mason MJ, Niedzwiecki D, Nesbakken A, et al. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II\/III colorectal cancer. Ann Oncol. 2019;30:1622\u20139.","journal-title":"Ann Oncol"},{"key":"9059_CR54","doi-asserted-by":"crossref","unstructured":"Racle J, de Jonge K, Baumgaertner P, Speiser DE, Gfeller D. Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data. Elife.\u00a02017;6:e26476.","DOI":"10.7554\/eLife.26476"},{"key":"9059_CR55","doi-asserted-by":"publisher","unstructured":"Zhang H, Li R, Cao Y, Gu Y, Lin C, Liu X, Lv K, He X, Fang H, Jin K, et al. Poor clinical outcomes and Immunoevasive contexture in Intratumoral IL-10-producing macrophages enriched gastric Cancer patients. Ann Surg. 2020. https:\/\/doi.org\/10.1097\/SLA.0000000000004037.","DOI":"10.1097\/SLA.0000000000004037"},{"key":"9059_CR56","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359.","journal-title":"Methods Mol Biol"},{"key":"9059_CR57","first-page":"388","volume":"19","author":"GP Dai","year":"2020","unstructured":"Dai GP, Wang LP, Wen YQ, Ren XQ, Zuo SG. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis. Oncol Lett. 2020;19:388\u201398.","journal-title":"Oncol Lett"},{"key":"9059_CR58","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1126\/science.aaa4971","volume":"348","author":"TN Schumacher","year":"2015","unstructured":"Schumacher TN, Schreiber RD. Neoantigens in cancer immunotherapy. Science. 2015;348:69\u201374.","journal-title":"Science"},{"key":"9059_CR59","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/imr.12772","volume":"290","author":"SS Chandran","year":"2019","unstructured":"Chandran SS, Klebanoff CA. T cell receptor-based cancer immunotherapy: emerging efficacy and pathways of resistance. Immunol Rev. 2019;290:127\u201347.","journal-title":"Immunol Rev"},{"key":"9059_CR60","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/s41591-019-0596-y","volume":"25","author":"TN Yamamoto","year":"2019","unstructured":"Yamamoto TN, Kishton RJ, Restifo NP. Developing neoantigen-targeted T cell-based treatments for solid tumors. Nat Med. 2019;25:1488\u201399.","journal-title":"Nat Med"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-09059-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-09059-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T13:08:10Z","timestamp":1650287290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-09059-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9059"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-09059-x","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"30 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that all authors do not have competing interests related to this research project.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1347"}}